Dermatology Diagnostic Devices Market - By Product (Imaging Devices, Dermatoscopes, Microscopes), By Application (Skin Cancer, Psoriasis, Dermatitis, Hair & Scalp Disorders, Acne), By End-use (Dermatology Centers, Hospitals, Clinics) – Global Forecast to 2032

Dermatology Diagnostic Devices Market Size

Dermatology Diagnostic Devices Market size was valued at over USD 6 billion in 2022 and is anticipated to grow at a CAGR of over 9.6% between 2023 and 2032. Dermatology diagnostic devices refer to medical equipment used to diagnose various skin conditions and diseases. These devices use advanced technologies such as infrared imaging, ultrasound, and optical coherence tomography to provide detailed images and information about the skin. Global dermatology devices industry is estimated to witness over 10% CAGR through 2032 driven by rising inclination towards cosmetic procedures in developed nations.
 

Dermatology diagnostic devices are designed to detect and analyse changes in the skin, such as pigmentation, inflammation, and other abnormalities, to help dermatologists make accurate diagnoses and develop effective treatment plans. Increasing advancements in technology, shifting patient preference for better physical along with favorable demographic trends are aspects boosting product demand for dermatology diagnostic devices market.
 

Moreover, utilization of technologically advanced dermatology diagnostic devices for several skin disorders as well as for aesthetic procedures should impel dermatology diagnostic devices industry growth in upcoming years. Furthermore, growing cases of skin cancers should escalate demand for dermatology devices. Skin cancers are more prevalent in tropical countries such as India, Japan. Population living in tropical regions is more exposed to UV radiations that increases risk of skin cancers. According to DNA India, there is an increase in prevalence of nonmelanoma cancer that should enhance dermatology devices industry growth during the forecast period.
 

COVID-19 Impact

The COVID-19 pandemic had a moderate impact on the dermatology diagnostic devices market. During the pandemic, postponement or reduction of several non-essential diagnostic procedures and screenings to minimize the risk of virus transmission which restricted overall market demand. Also, declined patient visits to clinical settings adversely impacted on the product demand. Further, significant shift in healthcare research and development activities towards COVID-19-related diagnostics, treatments, and vaccines. This diversion of resources and attention temporarily impacted the development of new dermatology diagnostics devices and slowed down innovation in the field to some extent.
 

Dermatology Diagnostic Devices Market Trends

Growing awareness regarding skin diseases and disorders coupled with willingness to spend more on skin care treatments are factors boosting global market growth. Technological advancements that are offering enhanced devices for skin care and availability of such devices will surge adoption of dermatology diagnostic devices for precised diagnostics. Women as well as men seeking skincare treatments for aesthetic appeal and individuals facing skin problems are adopting skincare treatments though the cost for treatment is high. Furthermore, advanced skincare diagnostic tools and customer services offered add up to the consumers experience thereby boosting dermatology devices market growth. Additionally, professional skincare analysis offered and availability of different solutions for dermatologic conditions fuels business growth. 
 

Dermatology Diagnostic Devices Market Analysis

Based on product, the industry is segmented into imaging devices, dermatoscopes, microscopes and others. Imaging devices segment held largest market share in the dermatology diagnostic devices market accounted for more than 59% revenue share in 2022. Increasing usage of imaging devices across the world is attributable to growing number of skin diseases such as psoriasis, skin lesions and myeloma. For instance, skin cancer is one of the lethal cancers highly prevailing across the globe. As per the American Society of Clinical Oncology (ASCO), it is estimated that in 2023, around 12,590 people will die of myeloma in the U.S. Hence, there is an emerging need for imaging devices that finds application in early diagnosis of disease, thereby boosting dermatology devices market.
 

The dermatology diagnostic devices market by application is categorized into skin cancer, psoriasis, dermatitis hair & scalp disorders, acne, and others. Psoriasis segment garnered significant revenue size in the year 2022 and is estimated to flourish enormous growth over the analysis timeframe. Increasing prevalence of psoriasis and technological advancement for the diagnosis of psoriasis and psoriatic arthritis is anticipated to propel dermatology diagnostic devices industry expansion. Further, numerous initiatives including campaigns, research funding towards advancing diagnosis and treatment for psoriasis undertaken by associations will positively impact dermatology diagnostics devices market growth.
 

The dermatology diagnostic devices market by end-use is segregated into dermatology centers, hospitals, clinics, and others. The dermatology centers segment is accounted for more than USD 2 billion market size in 2022 and is anticipated to foresee high growth potential over forecast period. High segmental growth is owing to patient inclination towards aesthetic procedures, increasing prevalence of several skin disorders especially skin cancer. Moreover, high availability and accessibility for advanced technology for enhanced patient outcome among settings stimulating segmental revenue growth.
 

U.S. dermatology diagnostic devices market accounted for more than USD 2 billion in 2022 and will grow momentously more than USD 4 billion by 2032. High revenue size is primarily owing to the increasing incidence of skin cancers coupled with rising healthcare expenditure. Technological advancements in dermatology diagnostic devices will drive country’s business growth. High adoption of advanced diagnostic devices for atopic psoriasis, acne, and other skin conditions for enhanced success rates will augment dermatology diagnostic devices business growth. Further, rising R&D investments for early detection of skin cancer and treatment procedures by major industry players will have significant impact on industry growth. Strong presence of prime competitors emphasizing on novel product launch will boost industry statistics in the U.S.
 

Dermatology Diagnostic Devices Market Share

Some of the notable key industry players operating in the dermatology diagnostic devices market include:

• Carl Zeiss Meditec AG
• Caliber I.D Inc 
• Michelson Diagnostics Limited
• STRATA Skin Sciences (MELA Sciences, Inc)
• BOMTECH ELECTRONICS CO
• Canfield Imaging Systems
• ILLUCO Corporation Ltd
• Nikon Corporation
• DermoScan GmbH
• Abbott Diagnostics
• Leica Microsystems GmbH
• Bruker Corporation
   

These industry participants are implementing several growth strategies such as collaborations, partnerships, acquisitions & mergers, and new product development and launches to strengthen product offerings as well as gain a competitive edge over others.
 

Dermatology Diagnostic Devices Industry News:

• In August 2022, Caliber Imaging & Diagnostics, Inc. merged with VivaScope GmbH. This has expanded company’s development capabilities and product offerings in the medical imaging including dermatology diagnostics devices market.
   
• In December 2021, Canfield Scientific, Inc. acquired Medici Medical s.r.l. a prominent player in dermoscopy innovations and solutions and announced launch of Canfield Scientific s.r.l. in Italy. This has helped company to broaden its operational capabilities.
   

Dermatology diagnostic devices market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2018 to 2032 for the following segments:

Click here to Buy Section of this Report

By Product

• Imaging devices
• Dermatoscopes
• Microscopes
• Others

By Application

• Skin cancer
• Psoriasis
• Dermatitis
• Hair and scalp disorders
• Acne
• Others

By End-use

• Dermatology centers
• Hospitals
• Clinics
• Others

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Switzerland
  • The Netherlands
  • Poland
  • Sweden
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • New Zealand
  • Indonesia
  • Thailand
  • Vietnam
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Chile
  • Peru
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Iran